What is the recommended treatment plan for a patient with a positive Ureaplasma (Ureaplasma spp NAA) test result, mildly elevated Low-Density Lipoprotein (LDL) cholesterol, elevated eosinophils, and low-normal Hemoglobin A1c, presenting with potential symptoms such as discharge, irritation, or pelvic discomfort?

Treatment Plan for Positive Ureaplasma with Associated Laboratory Findings

Ureaplasma Management: Symptom-Dependent Treatment

Treat Ureaplasma only if the patient is symptomatic with discharge, irritation, or pelvic discomfort; asymptomatic colonization does not require treatment. 1, 2

When to Treat Ureaplasma

• Symptomatic patients presenting with mucopurulent discharge, dysuria, urethral pruritus, or pelvic discomfort should receive antibiotic therapy 1
• Asymptomatic patients with positive Ureaplasma testing should NOT be treated, as the pathogenic role of Ureaplasma (particularly U. parvum) remains questionable 2, 3
• The 2024 European Association of Urology guidelines note that U. urealyticum (but not U. parvum) is considered a true aetiological agent of non-gonococcal urethritis 1

First-Line Antibiotic Regimen

Doxycycline 100 mg orally twice daily for 7 days is the recommended first-line treatment, achieving 91% susceptibility rates 4, 5, 2

• Treatment duration: 7 days for women; 14 days for men when prostatitis cannot be excluded 1, 5
• This regimen provides optimal microbiologic cure and symptom resolution 1, 4

Alternative Regimens

If doxycycline cannot be used due to contraindications or compliance concerns:

• Azithromycin 1 g orally as a single dose (71% susceptibility; preferred when compliance is questionable) 4, 5, 2
• Erythromycin base 500 mg orally four times daily for 7 days 1, 4
• Erythromycin ethylsuccinate 800 mg orally four times daily for 7 days 1, 4

Critical Exclusions Before Treatment

Before attributing symptoms to Ureaplasma, always exclude Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium through appropriate testing 1, 2

• These organisms are more common causes of urethritis and require different treatment approaches 1
• Testing should be performed before initiating therapy when possible 1

Partner Management

All sexual partners with contact within 60 days of diagnosis must be evaluated and treated 4, 5, 2

• Both patient and partners must abstain from sexual intercourse for 7 days after single-dose therapy or until completion of 7-day regimen 4, 5, 2
• This prevents reinfection and treatment failure 4

Follow-Up Strategy

• Test-of-cure is NOT routinely recommended after doxycycline or azithromycin unless symptoms persist 2
• Patients should return for evaluation only if symptoms persist or recur after completing therapy 1, 4
• Re-treatment with the initial regimen is appropriate if non-compliance or partner re-exposure occurred 4, 2

---

LDL Cholesterol Management: Lifestyle Modification First

For LDL cholesterol of 124 mg/dL in a patient without established cardiovascular disease, initiate lifestyle modifications with repeat lipid panel in 6-12 months before considering pharmacotherapy.

• Heart-healthy diet emphasizing reduced saturated fat intake
• Increased physical activity (minimum 150 minutes moderate-intensity exercise weekly)
• Weight management if BMI is elevated
• Reassess cardiovascular risk factors at follow-up

---

Eosinophilia Management: Clinical Correlation Required

Mild eosinophilia (0.7 × 10⁹/L) requires clinical correlation with allergy symptoms, asthma history, or recent parasitic exposure; no treatment is needed if asymptomatic.

• Evaluate for allergic rhinitis, asthma, eczema, or drug reactions
• Consider parasitic infection if travel history or exposure risk exists
• Monitor trend on repeat complete blood count if symptoms develop

---

Hemoglobin A1c: No Intervention Required

Hemoglobin A1c of 4.7% is low-normal and requires no intervention; this excludes diabetes and prediabetes.

• No diabetes screening needed at this time
• Routine monitoring per age-appropriate guidelines

---

Common Pitfalls to Avoid

• Do not treat asymptomatic Ureaplasma colonization, as this promotes antibiotic resistance without clinical benefit 2, 3
• Do not assume Ureaplasma is the causative pathogen without excluding more common sexually transmitted infections 2
• Do not use fluoroquinolones empirically for urethritis if the patient has used them in the last 6 months or has urology department exposure 1
• Do not initiate statin therapy for mildly elevated LDL without first attempting lifestyle modifications in low-risk patients